Siddarth Selvaraj
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$11.4MFederal grants as PI12 awards
0Patents grantedNone matched
36Papers18,618 citations
Federal awards and patents by year
AwardsPatents
12 awards · $11.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 1, 2024 | NIH | SBIR Phase II Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors | $1.9M | ARIMA GENOMICS, INC. |
| May 1, 2023 | NIH | SBIR Phase II Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors | $2.1M | ARIMA GENOMICS, INC. |
| Mar 3, 2021 | NIH | SBIR Phase II Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies | $999K | ARIMA GENOMICS, INC. |
| Apr 20, 2020 | NIH | SBIR Phase II Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies | $999K | ARIMA GENOMICS, INC. |
| Mar 26, 2019 | NIH | SBIR Phase II Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information | $174K | ARIMA GENOMICS, INC. |
| Mar 7, 2018 | NIH | SBIR Phase II Commercialization of a low-cost user-friendly DNA preparation kit that produces chromosome-span contiguity from conventional short-read sequencing for a wide range of applications | $928K | ARIMA GENOMICS, INC. |
| Mar 2, 2018 | NIH | SBIR Phase II Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information | $1.7M | ARIMA GENOMICS, INC. |
| Apr 17, 2017 | NIH | SBIR Phase II Commercialization of a low-cost user-friendly DNA preparation kit that produces chromosome-span contiguity from conventional short-read sequencing?? for a wide range of applications | $1.8M | ARIMA GENOMICS, INC. |
| Apr 12, 2017 | NIH | SBIR Phase I Maximal resolution and full-length phasing for next-generation MHC-typing | $50K | ARIMA GENOMICS, INC. |
| Jul 12, 2016 | NIH | SBIR Phase I Maximal resolution and full length phasing for next generation MHC typing | $274K | ARIMA GENOMICS, INC. |
| Jul 11, 2016 | NIH | SBIR Phase I Maximal resolution and full-length phasing for next-generation MHC-typing | $225K | ARIMA GENOMICS, INC. |
| May 11, 2016 | NIH | SBIR Phase I Non-invasive determination of complete fetal genomes from cfDNA using HaploSeq | $291K | ARIMA GENOMICS, INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#47
Awards as PI#86
Patents#273
Companies
- ARIMA GENOMICS, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.